Riskpilot← Back to searchSign inGet full accessSANDNES KLINIKKEN AS
ASActiveOrg 995412403Solaveien 88, 4316 SandnesGeneral medical practice activities · NACE 8621Est. 20105 employeeswww.sandnes-klinikken.no
Revenue 2024
NOK 4,9M
+14% vs 2023
EBITDA margin
1.3%
+156% vs 2023
Equity ratio
15.1%
Financial strength
Net profit 2024
NOK 34K
+605% vs 2023
| Revenue | NOK 4,9M | +14% |
| EBITDA | NOK 62K | +156% |
| Net profit | NOK 34K | +605% |
| Total assets | NOK 616K | +4% |
| Equity | NOK 93K | +56% |
| Employees | 5 | — |
Legal name
SANDNES KLINIKKEN AS
Org number
995412403
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
19. april 2010
Share capital
NOK 100 200
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av kontorfellesskap for næringsdrivende utøvere av helsetjenester, så som kjøp av inventar, utstyr og forbruksmateriell. Leie av lokaler og arbeidsgiver for ansatte helsepersonell.
Address
Solaveien 88, 4316 Sandnes
Phone
+4751685400
Website
www.sandnes-klinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 932 | 4 212 | 4 197 | 4 295 | 4 910 |
| Staff expenses | −2 122 | −2 327 | −2 299 | −2 213 | −2 708 |
| EBITDA | 64 | 11 | 28 | 24 | 62 |
| Depreciation & amort. | −63 | −11 | −28 | −26 | −18 |
| EBIT | 1 | 0 | 0 | −2 | 44 |
| Net financials | −1 | −0 | −0 | −1 | −1 |
| Profit before tax | 0 | 0 | −0 | −3 | 43 |
| Tax | 7 | −0 | −0 | 3 | 10 |
| Net profit | −7 | 0 | −0 | −7 | 34 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 634 | 822 | 675 | 595 | 616 |
| Equity | 66 | 66 | 66 | 59 | 93 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 568 | 756 | 609 | 536 | 523 |
| Total debt | 568 | 756 | 609 | 536 | 523 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
15.1%
This company
38.2%
Market median
-60% vs market
20202024
Return on equity
36.1%
This company
18.4%
Market median
+96% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
7.96×
This company
1.12×
Market median
+611% vs market
20202024
Debt / equity
5.63×
This company
0.62×
Market median
-808% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TK Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.33% | 33.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SANDNES KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Kleiberg Jensen | Chief Executive Officer | 0 companies |
| Cathrine Fossen | Board of Directors | 0 companies |
| Madeleine Kerstin Müller-Hubrich | Chairman | 0 companies |